Rhinitis, Allergic: Clinical Trials

137 trials for Rhinitis, Allergic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

137 completed. 137 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4137Completed 137

Follow Rhinitis, Allergic: new trials by email Literature Review of Rhinitis, Allergic trials Research Report on Rhinitis, Allergic

Trials (filtered) newest first · largest first

All 137 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dymista in Chinese Adolescents
Treatment with 137 µg azelastine hydrochloride and 50 μg of fluticasone propionate - Allergic Rhinitis Due to Allergens
Phase 4CompletedViatris Inc.1002026-05-082026-11-03
Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above
Fexofenadine HCL and pseudoephedrine HCL - Rhinitis Allergic
Phase 4CompletedSanofi2032025-06-152026-02-17
Evaluation of Treatments for Allergic Rhinitis (Rhinal 2)
ALLERSPRAY-G (device A), PCNS (device B) - Allergic Rhinitis
Phase 4CompletedUniversity Hospital, Clermont-Ferrand352025-03-032025-06-13
Oxymetazoline Bridge Therapy With Intranasal Corticosteroids in Pediatric Allergic Rhinitis
Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 100 mcg, Oxymetazoline 0.05% nasal solution - Persistent Allergic Rhinitis
Phase 4CompletedDr. Behcet Uz Children's Hospital762025-01-022026-05-18
Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients
Budesonide buffered with 0.9% isotonic saline., Fluticasone propionate nasal spray., 0.9% saline for nasal irrigation. - Nasal Allergy
Phase 4CompletedBenha University3602023-08-152025-03-05
Diphenhydramine and Sweating
Placebo, Diphenhydramine - Diphenhydramine Causing Adverse Effects in Therapeutic Use, Hyperthermia
Phase 4CompletedLakehead University202022-11-212023-09-13
Effects of Second-generation Antihistamine Bepotastine on Cough Outcomes in Cough Patients With Allergic Rhinitis
Bepotastine, Placebo - Allergic Rhinitis, Cough
Phase 4CompletedAsan Medical Center502021-10-012023-01-05
Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis
Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Azelastine Nasal 140 Mcg/Inh Nasal Spray, Fluticasone Nasal 50 Mcg/Inh Nasal Spray - Allergic Rhinitis
Phase 4CompletedZheng Liu ENT1822021-09-092026-10-02
Dymista Allergen Chamber - Onset of Action Study
Treatment A (Dymista): Fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray at Visit 3, Treatment B (Placebo): Nasal spray with no active dose (Dymista vehicle) at Visit 5, Treatment A (Dymista): Fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray at Visit 5 - Seasonal Allergic Rhinitis
Phase 4CompletedMEDA Pharma GmbH & Co. KG2162020-12-142023-03-23
Novel Dose Adjustment Schedule for Late Injection in SCIT in AR
Novel dose adjustment of Alutard SQ, conventional dose adjustment of Alutard SQ, Routine continuous cluster of Alutard SQ - Allergic Rhinitis, Immunotherapy
Phase 4CompletedBeijing Tongren Hospital1022020-06-112021-06-18
A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies
Loratadine (Claritin, BAY76-2211) - Allergic Rhinitis
Phase 4CompletedBayer4682019-11-122021-02-04
Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.
MethylPREDNISolone 40 Mg/mL Injectable Suspension, NaCl 9 MG/ML Injectable Solution - Rhinitis, Allergic, Seasonal, Hay Fever
Phase 4CompletedKarolinska Institutet442019-04-102024-03-15
The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study
Omalizumab - Allergic Rhinitis
Phase 4CompletedYuzuncu Yil University502019-01-012025-02-04
Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis
Mometasone Furoate Nasal Irrigation, Mometasone Nasal Spray - Chronic Rhinosinusitis (Diagnosis), Allergic Rhinosinusitis
Phase 4CompletedWashington University School of Medicine532019-01-012025-06-26
miRNA-155 Assay Before and After Immunotherapy and Probiotics
Lacteol fort, Standardized Timothy Grass Pollen, Lacteol fort and Standardized Timothy Grass Pollen - Allergic Rhinitis
Phase 4CompletedZagazig University452018-09-012020-10-29
Role of Montelukast in Asthma and Allergic Rhinitis Patients
Montelukast 10mg - Asthma and Allergic Rhinitis
Phase 4CompletedClinision6002018-08-282020-01-03
The Effect of Cetirizine on Bronchoconstriction
Cetirizine Hydrochloride 1 MG/ML, Placebo - Concentrate - Allergic Rhinitis, Asthma
Phase 4CompletedNew York City Health and Hospitals Corporation402018-05-112022-10-18
Nebulized Resveratrol Plus Carboxymethyl-β-Glucan for Reducing IL-5 in Children With Allergic Rhinitis
Resveratrol plus Carboxymethyl-β-Glucan, Placebo - Allergic Rhinitis
Phase 4CompletedIstituto per la Ricerca e l'Innovazione Biomedica882018-03-052019-12-05
A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure
loratadine + pseudoephedrine sulfate (BAY818725/Claritin-D), Placebo tablet, Fluticasone Propionate - Rhinitis, Allergic
Phase 4CompletedBayer822018-02-212019-12-20
MP-AzeFlu Allergen Chamber - Onset of Action Study
Azelastine hydrochloride + fluticasone propionate nasal spray, Placebos, fluticasone propionate nasal spray + loratadine - Seasonal Allergic Rhinitis
Phase 4CompletedMEDA Pharma GmbH & Co. KG822017-01-072022-02-22

Showing 20 of 137. Sign in to see all of them.

Narrower conditions

Rhinitis, Allergic, Seasonal (48)  ·  Rhinitis, Allergic, Perennial (30)  ·  Asthma (16)  ·  Rhinitis (11)  ·  Hypersensitivity (9)  ·  Nasal Obstruction (4)  ·  Rhinorrhea (3)  ·  Sneezing (3)  ·  Conjunctivitis, Allergic (2)  ·  Dermatitis, Atopic (2)  ·  Rhinosinusitis (2)  ·  Sleep Wake Disorders (2)  ·  Chronic Urticaria (1)  ·  Cough (1)

Broader conditions

Hypersensitivity, Immediate (137)  ·  Immune System Diseases (137)  ·  Nose Diseases (137)  ·  Otorhinolaryngologic Diseases (137)  ·  Respiratory Hypersensitivity (137)  ·  Respiratory Tract Diseases (137)  ·  Hypersensitivity (128)  ·  Rhinitis (126)  ·  Bronchial Diseases (16)  ·  Lung Diseases (16)  ·  Lung Diseases, Obstructive (16)  ·  Infections (12)  ·  Respiratory Tract Infections (12)  ·  Pathological Conditions, Signs and Symptoms (10)

Interventions

Fluticasone (17)  ·  fexofenadine (17)  ·  levocetirizine (16)  ·  montelukast (12)  ·  desloratadine (11)  ·  Cetirizine (10)  ·  Loratadine (8)  ·  Mometasone Furoate (8)  ·  fluticasone furoate (8)  ·  azelastine (6)  ·  Sodium Chloride (4)  ·  ciclesonide (4)  ·  Budesonide (3)  ·  Olopatadine Hydrochloride (3)  ·  Oxymetazoline (3)

Sponsors

Organon and Co (21)  ·  GlaxoSmithKline (14)  ·  Sanofi (9)  ·  University of Chicago (8)  ·  UCB Pharma (5)  ·  Alcon Research (4)  ·  Bayer (3)  ·  University of Dundee (3)  ·  AstraZeneca (2)  ·  Bayside Health (2)  ·  Brian J Lipworth (2)  ·  HAL Allergy (2)  ·  Institut für Atemwegsforschung GmbH (2)  ·  Istituto per la Ricerca e l'Innovazione Biomedica (2)  ·  Johnson & Johnson Consumer and Personal Products Worldwide (2)

Countries

United States (46)  ·  Canada (10)  ·  Italy (9)  ·  Poland (6)  ·  China (5)  ·  Germany (5)  ·  United Kingdom (5)  ·  Australia (3)  ·  South Korea (3)  ·  Argentina (2)  ·  Egypt (2)  ·  Estonia (2)  ·  France (2)  ·  Russia (2)  ·  Sweden (2)

Top investigators

Phyllis Diener (5)  ·  Robert M Naclerio, MD (4)  ·  Brian J Lipworth, MD (2)  ·  Claus Bachert, MD, PhD (2)  ·  Jay F Piccirillo, MD (2)  ·  Akbar Akbary, MD (1)  ·  Alessandra Sandrini, MD, PhD (1)  ·  Alicia Alonso, PhD, MD (1)  ·  Ana Navarro, PhD, MD (1)  ·  Anne K Ellis, MD (1)

Results publications

PMID 20167147, PMID 20642206, PMID 11558866, PMID 16140398, PMID 16278257, PMID 16846553, PMID 16913264, PMID 18331513, PMID 18399898, PMID 18430310, PMID 19127072, PMID 19187327, PMID 19428097, PMID 19504468, PMID 19696440, PMID 19788025, PMID 19804441, PMID 20110036, PMID 20203244, PMID 20350147, PMID 20377116, PMID 21055665, PMID 21067660, PMID 21377716, PMID 21518040, PMID 22192967, PMID 22230419, PMID 22289724, PMID 23147964, PMID 23331565, PMID 23406601, PMID 23636036, PMID 23786282, PMID 23981504, PMID 24574125, PMID 25017530, PMID 25198026, PMID 26108088, PMID 26582093, PMID 26740893, PMID 26755098, PMID 26948849, PMID 27332957, PMID 27696447, PMID 28668244, PMID 28848100, PMID 29079387, PMID 29371864, PMID 29461859, PMID 29768147

NIH funding

2004 (2), 2005 (1), 2015 (1)